Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, January 19, 2016
[ Tue, Jan 19th 2016
] - WOPRAI
[ Tue, Jan 19th 2016
] - WOPRAI
[ Tue, Jan 19th 2016
] - WOPRAI
[ Tue, Jan 19th 2016
] - WOPRAI
[ Tue, Jan 19th 2016
] - WOPRAI
[ Tue, Jan 19th 2016
] - WOPRAI
[ Tue, Jan 19th 2016
] - WOPRAI
[ Tue, Jan 19th 2016
] - WOPRAI
[ Tue, Jan 19th 2016
] - WOPRAI
[ Tue, Jan 19th 2016
] - WOPRAI
[ Tue, Jan 19th 2016
] - WOPRAI
[ Tue, Jan 19th 2016
] - WOPRAI
[ Tue, Jan 19th 2016
] - WOPRAI
Fri, January 15, 2016
[ Fri, Jan 15th 2016
] - WOPRAI
[ Fri, Jan 15th 2016
] - WOPRAI
[ Fri, Jan 15th 2016
] - WOPRAI
[ Fri, Jan 15th 2016
] - WOPRAI
[ Fri, Jan 15th 2016
] - WOPRAI
[ Fri, Jan 15th 2016
] - WOPRAI
[ Fri, Jan 15th 2016
] - WOPRAI
[ Fri, Jan 15th 2016
] - WOPRAI
[ Fri, Jan 15th 2016
] - WOPRAI
[ Fri, Jan 15th 2016
] - WOPRAI
Gena Wang Maintained (BMRN) at Buy with Decreased Target to $125 on, Jan 15th, 2016
Gena Wang of Barclays, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Decreased Target from $156 to $125 on, Jan 15th, 2016.
Gena has made no other calls on BMRN in the last 4 months.
There is 1 other peer that has a rating on BMRN. Out of the 1 peers that are also analyzing BMRN, 0 agree with Gena's Rating of Hold.
This is the rating of the analyst that currently disagrees with Gena
- Laura Chico of "Raymond James" Initiated at Buy and Held Target at $148 on, Friday, October 2nd, 2015
Similar Stocks and Investing Articles
[ Wed, Jan 06th 2016
] - WOPRAI
[ Wed, Oct 07th 2015
] - WOPRAI
[ Fri, Oct 02nd 2015
] - WOPRAI
[ Wed, Sep 30th 2015
] - WOPRAI
[ Wed, Jun 24th 2015
] - WOPRAI
[ Fri, Jun 05th 2015
] - WOPRAI
[ Tue, May 26th 2015
] - WOPRAI
[ Mon, Jan 05th 2015
] - WOPRAI
[ Fri, May 09th 2014
] - WOPRAI
[ Fri, Aug 24th 2012
] - WOPRAI